{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T14:10:04Z","timestamp":1767967804497,"version":"3.49.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,4,26]]},"DOI":"10.7759\/cureus.14701","type":"journal-article","created":{"date-parts":[[2021,4,26]],"date-time":"2021-04-26T19:14:26Z","timestamp":1619464466000},"source":"Crossref","is-referenced-by-count":1,"title":["Oxybutynin-Induced Hyperthermia in a Patient With Parkinson\u2019s Disease"],"prefix":"10.7759","author":[{"given":"Saad","family":"Ahmad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan Vincent M","family":"Reyes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Lieber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S1353-8020(09)70820-X","article-title":"Treatment of dysautonomia associated with Parkinson\u2019s disease","volume":"15","author":"Mostile G","year":"2009","unstructured":"Mostile G, Jankovic J. Treatment of dysautonomia associated with Parkinson\u2019s disease. Parkinsonism Relat Disord. 2009, 15:224-32. 10.1016\/S1353-8020(09)70820-X","journal-title":"Parkinsonism Relat Disord"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/bs.irn.2017.04.003","article-title":"Autonomic dysfunction in Parkinson's disease: cardiovascular symptoms, thermoregulation, and urogenital symptoms","volume":"134","author":"Jost WH","year":"2017","unstructured":"Jost WH. Autonomic dysfunction in Parkinson's disease: cardiovascular symptoms, thermoregulation, and urogenital symptoms. Int Rev Neurobiol. 2017, 134:771-85. 10.1016\/bs.irn.2017.04.003","journal-title":"Int Rev Neurobiol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/mds.10586","article-title":"Sweating dysfunction in Parkinson's disease","volume":"18","author":"Swinn L","year":"2003","unstructured":"Swinn L, Schrag A, Viswanathan R, Bloem BR, Lees A, Quinn N. Sweating dysfunction in Parkinson's disease. Mov Disord. 2003, 18:1459-63. 10.1002\/mds.10586","journal-title":"Mov Disord"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxicon.2008.11.013","article-title":"Disease-oriented approach to botulinum toxin use","volume":"54","author":"Jankovic J","year":"2009","unstructured":"Jankovic J. Disease-oriented approach to botulinum toxin use. Toxicon. 2009, 54:614-23. 10.1016\/j.toxicon.2008.11.013","journal-title":"Toxicon"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1590\/abd1806-4841.201755126","article-title":"Oxybutynin as an alternative treatment for hyperhidrosis","volume":"92","author":"Delort S","year":"2017","unstructured":"Delort S, Marchi E, Corr\u00eaa MA. Oxybutynin as an alternative treatment for hyperhidrosis. An Bras Dermatol. 2017, 92:217-20. 10.1590\/abd1806-4841.201755126","journal-title":"An Bras Dermatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/mds.21006","article-title":"Hyperhidrosis in Parkinson's disease","volume":"21","author":"Schestatsky P","year":"2006","unstructured":"Schestatsky P, Valls-Sol\u00e9 J, Ehlers JA, Rieder CR, Gomes I. Hyperhidrosis in Parkinson's disease. Mov Disord. 2006, 21:1744-8. 10.1002\/mds.21006","journal-title":"Mov Disord"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra011089","article-title":"Heat stroke","volume":"346","author":"Bouchama A","year":"2002","unstructured":"Bouchama A, Knochel JP. Heat stroke. N Engl J Med. 2002, 346:1978-88. 10.1056\/NEJMra011089","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200831020-00002","article-title":"Drug-induced hyperhidrosis and hypohidrosis: incidence, prevention and management","volume":"31","author":"Cheshire WP","year":"2008","unstructured":"Cheshire WP, Fealey RD. Drug-induced hyperhidrosis and hypohidrosis: incidence, prevention and management. Drug Saf. 2008, 31:109-26. 10.2165\/00002018-200831020-00002","journal-title":"Drug Saf"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1017\/neu.2015.29","article-title":"Heat stroke during treatment with olanzapine, trihexyphenidyl, and trazodone in a patient with schizophrenia","volume":"27","author":"Lee CP","year":"2015","unstructured":"Lee CP, Chen PJ, Chang CM. Heat stroke during treatment with olanzapine, trihexyphenidyl, and trazodone in a patient with schizophrenia. Acta Neuropsychiatr. 2015, 27:380-5. 10.1017\/neu.2015.29","journal-title":"Acta Neuropsychiatr"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197409122911106","article-title":"Heat stroke","volume":"291","author":"Clowes GH Jr","year":"1974","unstructured":"Clowes GH Jr, O'Donnell TF Jr. Heat stroke. N Engl J Med. 1974, 291:564-7. 10.1056\/NEJM197409122911106","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1186\/s40560-018-0298-4","article-title":"Heat stroke","volume":"6","author":"Hifumi T","year":"2018","unstructured":"Hifumi T, Kondo Y, Shimizu K, Miyake Y. Heat stroke. J Intensive Care. 2018, 6:30. 10.1186\/s40560-018-0298-4","journal-title":"J Intensive Care"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-016-1376-4","article-title":"The neurological and cognitive consequences of hyperthermia","volume":"20","author":"Walter EJ","year":"2016","unstructured":"Walter EJ, Carraretto M. The neurological and cognitive consequences of hyperthermia. Crit Care. 2016, 20:199. 10.1186\/s13054-016-1376-4","journal-title":"Crit Care"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1648231","article-title":"Hemostasis and thrombosis in extreme temperatures (hypo- and hyperthermia)","volume":"44","author":"Levi M","year":"2018","unstructured":"Levi M. Hemostasis and thrombosis in extreme temperatures (hypo- and hyperthermia). Semin Thromb Hemost. 2018, 44:651-5. 10.1055\/s-0038-1648231","journal-title":"Semin Thromb Hemost"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ucl.2006.06.003","article-title":"Oxybutynin in detrusor overactivity","volume":"33","author":"Diokno A","year":"2006","unstructured":"Diokno A, Ingber M. Oxybutynin in detrusor overactivity. Urol Clin North Am. 2006, 33:439-45, vii. 10.1016\/j.ucl.2006.06.003","journal-title":"Urol Clin North Am"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/BF01824208","article-title":"In vivo studies on receptor pharmacology of the human eccrine sweat gland","volume":"2","author":"Low PA","year":"1992","unstructured":"Low PA, Opfer-Gehrking TL, Kihara M. In vivo studies on receptor pharmacology of the human eccrine sweat gland. Clin Auton Res. 1992, 2:29-34. 10.1007\/BF01824208","journal-title":"Clin Auton Res"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/MOU.0b013e32832ce8a4","article-title":"Pharmacological treatment of overactive bladder: report from the International Consultation on Incontinence","volume":"19","author":"Andersson KE","year":"2009","unstructured":"Andersson KE, Chapple CR, Cardozo L, et al.. Pharmacological treatment of overactive bladder: report from the International Consultation on Incontinence. Curr Opin Urol. 2009, 19:380-94. 10.1097\/MOU.0b013e32832ce8a4","journal-title":"Curr Opin Urol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.1984.246.3.R321","article-title":"Circadian rhythm in sweating and cutaneous blood flow","volume":"246","author":"Stephenson LA","year":"1984","unstructured":"Stephenson LA, Wenger CB, O'Donovan BH, Nadel ER. Circadian rhythm in sweating and cutaneous blood flow. Am J Physiol. 1984, 246:R321-4. 10.1152\/ajpregu.1984.246.3.R321","journal-title":"Am J Physiol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.2165\/00002512-200320110-00007","article-title":"Transdermal oxybutynin: for overactive bladder","volume":"20","author":"Bang LM","year":"2003","unstructured":"Bang LM, Easthope SE, Perry CM. Transdermal oxybutynin: for overactive bladder. Drugs Aging. 2003, 20:857-64. 10.2165\/00002512-200320110-00007","journal-title":"Drugs Aging"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1080\/23328940.2016.1143760","article-title":"Characteristics of hyperthermia-induced hyperventilation in humans","volume":"3","author":"Tsuji B","year":"2016","unstructured":"Tsuji B, Hayashi K, Kondo N, Nishiyasu T. Characteristics of hyperthermia-induced hyperventilation in humans. Temperature (Austin). 2016, 3:146-60. 10.1080\/23328940.2016.1143760","journal-title":"Temperature (Austin)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/56597-oxybutynin-induced-hyperthermia-in-a-patient-with-parkinsons-disease","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:28:15Z","timestamp":1707506895000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/56597-oxybutynin-induced-hyperthermia-in-a-patient-with-parkinsons-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,26]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.14701","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4,26]]}}}